Nifty Smallcap 100 Enters Bear Phase; Pharma Stocks Lead Sell-Off

Stock Market Highlights – February 14, 2025

The Nifty Smallcap 100 index officially entered an enduring phase on Friday, losing about 22% from its peak of nineteen,716.20. The index tumbled nearly 4% to close at 15,373.70, signaling intense promoting pressure within the broader market.

The weak spot turned into now not constrained to small-caps—midcap shares also took a hit, with the Nifty Midcap 100 and 50 indexes declining 2.5% to settle at 18,325.40, as per NSE statistics.

Key Market Movers:

Pharma shares confronted sharp promoting stress, pushed by using reciprocal tariff threats from the United States on Thursday.
Natco Pharma and Laurus Labs had been among the worst-hit, every tumbling over 9%.

Other good-sized losers from the Nifty Smallcap one hundred index protected:

  • IFCI
  • Glenmark Pharma
  • Finolex Cables
  • HFCL
  • BEML

Apar Industries

Each of these stocks noticed a decline of over 7% on Friday.
The broader sell-off reflects investor caution amid worldwide exchange tensions and coverage uncertainty. Market participants will intently reveal similar trends in US-India change members of the family and their capacity effect on home equities.

Disclaimer:
This article is for informational functions and does now not represent monetary or investment recommendations. Investors ought to behavior their studies or seek advice from a professional monetary advisor earlier than making investment selections. Stock markets are difficult to risk, such as volatility and capability capital loss.